Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C2 | P52895 | 3/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.39 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.39 |
| ▸ | KCNK10 | P57789 | 1/20 | 0.39 |
| ▸ | PLK1 | P53350 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6835806 | 0.83 | POLB (0.45) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 | |
| SCHEMBL6834061 | 0.81 | POLB (0.46) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 | |
| SCHEMBL6929464 | 0.79 | AKR1C2 (0.43) | AKR1C2AKR1C1AKR1C4AKR1C3MAPT | |
| SCHEMBL6830007 | 0.78 | MEN1 (0.44) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 | |
| SCHEMBL6830237 | 0.76 | RPA1 (0.47) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 | |
| SCHEMBL6833361 | 0.72 | PPARG (0.49) | AKR1C2AKR1C1AKR1C4AKR1C3MAPT | |
| SCHEMBL6819031 | 0.71 | METAP2 (0.46) | AKR1C2AKR1C1AKR1C4AKR1C3MAPT | |
| SCHEMBL6830408 | 0.69 | SMN1; SMN2 (0.48) | AKR1C2AKR1C1AKR1C4AKR1C3MEN1 | |
| SCHEMBL14075210 | 0.68 | PLK1 (0.69) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 | |
| SCHEMBL6346862 | 0.67 | AKR1C2 (0.80) | AKR1C2AKR1C1POLBAKR1C4AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | AKR1C2 2596/4885AKR1C1 2161/4885POLB 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.